New Clinical Findings Coincide with the CE Approval and European Commercial Launchof the Revolutionary New Prostate Imaging and Biopsy System
MILAN, Italy, Nov. 24, 2016 /PRNewswire/ - Exact Imaging (www.exactimaging.com), the world's leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance of the prostate, will have
"We are honored to have four separate sessions and posters discussing our ExactVu micro-ultrasound technology at such a prestigious gathering of leaders in urological imaging," says Randy AuCoin, Exact Imaging's President and CEO. "With our recently received CE approval, we are excited to be able to work with so many leading urology clinics and institutions that have expressed interest in acquiring our technology to address their targeted biopsy needs".
Exact Imaging's ExactVu micro-ultrasound technology is being profiled in 2 clinical talks:
In addition, recent clinical findings with the ExactVu micro-ultrasound are also being presented as scientific posters at ESUI:
As the ExactVu micro-ultrasound has recently received CE marking (Certificate #649960) enabling sales of the system in Europe, it will also be on display in Booth #11 in the Exhibit Hall at ESUI.
About Exact Imaging:
Exact Imaging (www.exactimaging.com) is the world's leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Exact Imaging's ExactVu™ micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and being an extension of the current urological workflow. Using the Exact Imaging platform, urologists will now be able to visualize areas of interest in the prostate and specifically target biopsies at those areas in addition to performing systematic, transrectal, ultrasound biopsy protocols. The ExactVu™ micro-ultrasound system has CE marking (Certificate #649960) for sale in the European Union. The product is not yet commercially available in the US and Canada. The company was founded in 2013 by Sam Ifergan (iGan Partners) and Randy AuCoin to develop and commercialize this novel high-resolution technology to disrupt the market and enable new levels of clinical imaging.
SOURCE Exact Imaging
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All